Is OYST or XYLD a better dividend investment in 2026?

OYST currently yields 17.91% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: OYST offers higher current income.

What is the dividend yield difference between OYST and XYLD?

OYST has a forward dividend yield of 17.91% ($2.00/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 6.93 percentage points.

Home › Compare › OYST vs XYLD

OYST vs XYLD: Dividend Comparison 2026

OYST yields 17.91% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 OYST wins by $38.9K in total portfolio value

INVESTMENT

TIME HORIZON10 years

OYST

● Live price

17.91%

Share price

$11.17

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$64.2K

Annual income

$5,352.81

Full OYST calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — OYST vs XYLD

📍 OYST pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	OYST	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, OYST + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

OYST pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OYST

Annual income on $10K today (after 15% tax)

$1,521.93/yr

After 10yr DRIP, annual income (after tax)

$4,549.89/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, OYST beats the other by $1,813.72/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OYST + XYLD for your $10,000?

OYST: 50%XYLD: 50%

100% XYLD50/50100% OYST

Portfolio after 10yr

$44.7K

Annual income

$4,285.92/yr

Blended yield

9.58%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OYST buys

XYLD buys

No recent congressional trades found for OYST or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricOYSTXYLD

Forward yield	17.91% ✓	10.98%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$64.2K ✓	$25.3K
Annual income after 10y	$5,352.81 ✓	$3,219.02
Total dividends collected	$34.4K ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: OYST vs XYLD ($10,000, DRIP)

Year	OYST Portfolio	OYST Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$12,491	$1,790.51	$10,818	$1,098.39	+$1.7K → OYST
2	$15,455	$2,090.13	$11,738	$1,222.51	+$3.7K → OYST
3	$18,954	$2,417.01	$12,774	$1,364.64	+$6.2K → OYST
4	$23,051	$2,770.27	$13,944	$1,527.86	+$9.1K → OYST
5	$27,813	$3,148.68	$15,270	$1,715.87	+$12.5K → OYST
6	$33,311	$3,550.65	$16,775	$1,933.09	+$16.5K → OYST
7	$39,617	$3,974.27	$18,490	$2,184.87	+$21.1K → OYST
8	$46,807	$4,417.42	$20,450	$2,477.63	+$26.4K → OYST
9	$54,962	$4,877.76	$22,697	$2,819.19	+$32.3K → OYST
10	$64,162	$5,352.81	$25,280	$3,219.02	+$38.9K → OYST

OYST vs XYLD: Complete Analysis 2026

OYST — Stock

As of January 3, 2023, Oyster Point Pharma, Inc. was acquired by Viatris Inc. Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry eye disease. It is also developing TYRVAYA that is in Phase II clinical trial for the treatment of for neurotrophic keratopathy. The company was incorporated in 2015 and is headquartered in Princeton, New Jersey.

Full OYST Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this OYST vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OYST vs SCHD OYST vs JEPI OYST vs O OYST vs KO OYST vs MAIN OYST vs QYLD OYST vs JEPQ OYST vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.